Viking Therapeutics aims to participate in the billion-dollar obesity market. The company’s most advanced candidate is in a phase 3 trial. Pharmaceutical and biotech companies may offer your portfolio ...
XRP (XRP) trades $1.30-$1.40, with EGRAG projecting $42 (2,900% gain) while most analysts forecast $3-$8. EGRAG bases his $42 XRP forecast on a chart pattern that repeated across four cycles since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results